ONCTERNAL THERAP.    O.N.
ONCTERNAL THERAP. O.N.
Share · US68236P2065 · ONCT · A40063 (XNCM)
Overview Financial Indicators
No Price
n/a

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
- - - - -0,02 % -92,94 % -98,98 %

Firmenprofil zu ONCTERNAL THERAP. O.N. Aktie

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.

Unternehmensdaten

Name ONCTERNAL THERAP. O.N.
Firma Oncternal Therapeutics, Inc.
Symbol ONCT
Website https://www.oncternal.com
Heimatbörse XNCM Frankfurt
WKN A40063
ISIN US68236P2065
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. James B. Breitmeyer M.D., Ph.D.
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,0 T
Adresse 12230 El Camino Real, 92130 San Diego
IPO Datum 2004-02-03

Kennungs-Wechsel

Datum Von Zu
10.06.2019 GTXI ONCT

Ticker Symbole

Name Symbol
NASDAQ ONCT

Weitere Aktien

Investoren die ONCTERNAL THERAP. O.N. die halten, haben auch folgende Aktien im Depot:
NRG ENERGY 20/31 REGS
NRG ENERGY 20/31 REGS Anleihe
POSTNL 24/31
POSTNL 24/31 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025